动态共价的脂质纳米颗粒调解CRISPR-Cas9基因组编辑,以对抗小鼠的胆道新血管化
Desheng Cao1, Junliang Zhu1, Yang Guo2
1Institute of Functional Nano and Soft Materials (FUNSOM), Jiangsu Key Laboratory for Carbon-Based Functional Materials and Devices, Soochow University, Suzhou 215123, China.
Science advances
|July 11, 2025
概括
研究人员开发了用于基因编辑的新型脂质纳米粒子 (LNP),用于治疗胆道新血管化 (CNV). 这种新方法有效地降低了CNV,并优于现有的治疗方法.
科学领域:
- 生物医学工程 生物医学工程
- 基因治疗 基因治疗
- 眼科医生 眼科 眼科
背景情况:
- 目前使用血管内皮生长因子A (VEGFA) 抑制剂治疗胆道新血管化 (CNV) 的治疗方法存在局限性.
- 这些局限性包括低响应率,患者不合格以及潜在的眼损伤.
研究的目的:
- 为VEGFA基因编辑和CNV治疗设计动态共价脂质纳米粒子 (LNPs).
- 开发一个强大的非病毒平台,用于mRNA输送和基因组编辑.
主要方法:
- 合成了一系列脂类素与伊米诺酸乙烯链接的库.
- 将表现最好的脂类蛋白 (A4B3C7) 合成LNP (LNP-A4B3C7) 用于代码传递Cas9 mRNA (mCas9) 和sgRNA向VEGFA (sgVEGFA).
- 在视网膜色素上皮细胞中证明了H2O2触发的LNP解离和mRNA/sgRNA释放.
主要成果:
- 通过LNP-A4B3C7.7.实现了高mRNA转染效率.
- 由于触发释放,展示了增强的基因编辑效率.
- 在激光诱导的中枢神经瘤小鼠中,单次静脉内注射mCas9/sgVEGFA@LNP-A4B3C7导致显著的VEGFA干扰和中枢神经瘤区域减少.
- 临床LNP治疗证明了持续的治疗效果优于临床抗VEGF药物.
结论:
- 建立了一个强大的非病毒平台,用于mRNA输送和基因组编辑.
- 提出了一种有前途的治疗策略来治疗CNV.
更多相关视频
07:23Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
Published on: May 30, 2025
646
13:47Lentiviral Vector Platform for the Efficient Delivery of Epigenome-editing Tools into Human Induced Pluripotent Stem Cell-derived Disease Models
Published on: March 29, 2019
9.8K
相关概念视频
01:28CRISPR/Cas9 Genome Editing
272
The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
272
01:59CRISPR
53.0K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
53.0K